Re-Treatment Study of Probuphine in Opioid Addiction
NCT01262261
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
85
Enrollment
INDUSTRY
Sponsor class
Conditions
Opioid Dependency
Interventions
DRUG:
Probuphine (buprenorphine implant)
Sponsor
Titan Pharmaceuticals